Option chain shows key data for Viveon Health Acquisition's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Viveon Health Acquisition.

Viveon Health Acquisition (OTC:VHAQ) Stock, Option Chain

Viveon Health Acquisition Corp is a blank check company. It is formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses.

Biotech

News

Health Care

Financing

IPOs

General

VHAQ

Suneva Medical Inc, medical aesthetics player, will soon form a 

Regenerative Aesthetics Firm Suneva Medical Gets SPAC Support To Go Public

VIVEON HEALTH ACQ CRP by Viveon Health Acquisition Corp.

Viveon Health Acquisition Corp

VIVEON HEALTH ACQUISITION CORP RT

Viveon Health Acquisition Corp Units (1 Ord ,1 War & 1 Right )

Viveon Health Acquisition Corp Warrants (01/01/9999)

Rigetti Computing's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NYSE">RGTI</a>) short percent of float has risen 4.19% since its last report. The company recently reported that it has 36.31 million shares sold short, which is 14.18% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Rigetti Computing Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736440215_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Rigetti Computing has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Rigetti Computing's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Rigetti Computing's peer group average for short interest as a percentage of float is 8.63%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

RGTI

Peering Into Rigetti Computing's Recent Short Interest

Best Buy Co's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) short percent of float has risen 16.33% since its last report. The company recently reported that it has 13.43 million shares sold short, which is 8.05% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.84 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Best Buy Co Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736440210_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Best Buy Co has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Best Buy Co's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Best Buy Co's peer group average for short interest as a percentage of float is 2.87%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Best Buy Co's Recent Short Interest

Wildfires continue to ravage Los Angeles county on Thursday, causing billions of dollars in damage to <a href="https://www.benzinga.com/news/25/01/42894683/los-angeles-wildfires-stoke-investor-fears-edison-internationals-stock-ended-10-lower-on-wednesday-amid-concerns-over-possible-equipment-links-to-forest-fires">homes and businesses</a>. 
What To Know: Accuweather on Wednesday<a href="https://www.accuweather.com/en/blogs-webinars/california-wildfires-52-57b-damage-estimate-accuweather-report/1731718"> issued a</a> preliminary estimate of the total damage and economic loss from the Southern California wildfires to be between $52 billion and $57 billion.&nbsp;
More than 2,000 structures have been damaged or destroyed and additional damages are expected as red flag warnings continue through Thursday.&nbsp;
Read Next: <a href="https://www.benzinga.com/25/01/42878466/wildfire-rips-through-las-pacific-palisades-neighborhood-3000-acres-burned-30000-evacuated-homes-destroyed">Wildfire Rips Through LA&#8217;s Pacific Palisades Neighborhood Destroying Homes: 3,000 Acres Burned As 30,000 Residents Evacuate&nbsp;</a>
Five fires continue to burn in Los Angeles County on Thursday, with officials reporting the Palisades fire and the Eaton fire remain at zero containment,<a href="https://www.latimes.com/california/story/2025-01-08/fire-weather-fierce-winds-los-angeles"> according </a>to the Los Angeles Times. 
"This is already one of the worst wildfires in California history. Should a large number of additional structures be burned in the coming days, it may become the worst wildfire in modern California history based on the number of structures burned and economic loss," AccuWeather Chief Meteorologist Jonathan Porter said.
California Insurance Industry: California faced an insurance crisis before the fires began, as insurers were already fleeing the state due to massive losses caused by larger and more frequent wildfires. 
Actor James Woods highlighted the problem in a social media post, saying that a major insurance company had recently canceled the policies in his neighborhood. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Actually one of the major insurances companies canceled all the policies in our neighborhood about four months ago. <a href="https://t.co/JS03dsV9rF">https://t.co/JS03dsV9rF</a>
&mdash; James Woods (@RealJamesWoods) <a href="https://twitter.com/RealJamesWoods/status/1876875152236941482?ref_src=twsrc%5Etfw">January 8, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Many homes in the affected areas are insured by the state-backed insurer of last resort, the California FAThe plans are more expensive and provide less coverage than traditional private plans.
Tim Zawacki, an insurance sector strategist at S&amp;P Global Market Intelligence,<a href="https://www.nytimes.com/2025/01/08/climate/california-homeowners-insurance-fires.html"> told The</a> New York Times the number of homes in the ZIP code affected by the Palisades fire that are enrolled in the FAIR Plan has nearly doubled over the last year.
Experts are concerned the destruction caused by the ongoing fires could exacerbate the insurance crisis in the state. Equity analysts are forecasting potential insurance industry losses of between $6 billion and $13 billion, <a href="https://www.reinsurancene.ws/analysts-peg-insured-la-wildfire-losses-at-up-to-13bn-economic-loss-put-at-more-than-52bn/">according to</a> Reinsurance News. 
Some of the largest property insurers in California include Allstate Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) and The Travelers Companies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>).
BMO Capital Markets analysts estimate that at around a $3.5 billion insured loss, the fires could add risk to first-quarter earnings per share estimates for reinsurers, per Reinsurance News. 
The analysts added that a loss of more than $7 billion, would affect first-quarter earnings results across the insurance and reinsurance sector.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/42854890/us-records-first-human-bird-flu-death-high-levels-of-respiratory-illnesses-vaccine-stocks-rally">US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally </a></li>
</ul>
Photo via Shutterstock.

Markets

Insurance

LA Wildfire Damages Could Top $52 Billion As California Faces Property Insurance Crisis

Jefferies Financial Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) delivered mixed <a href="https://www.benzinga.com/pressreleases/25/01/b42886369/jefferies-announces-fourth-quarter-2024-financial-results">fourth-quarter results</a> after Wednesday&#8217;s closing bell, with earnings falling short of expectations but analysts highlighting the company's strong position to benefit from a capital markets recovery.
The company delivered a "modest miss" in earnings of 93 cents per share versus the consensus of 98 cents per share, mainly due to softer-than-expected margins and a lower-quality revenue mix, according to Goldman Sachs.
The Jefferies Financial Group Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6149a1cd46584a00014583f4/james-yaro">Analyst James Yaro</a> maintained a Buy rating for Jefferies Financial Group, while raising the price target to $87. 
The Jefferies Financial Group Thesis: The company's core pre-tax margins missed Street expectations by 215 basis points, Yaro said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
While Jefferies Financial Group's core revenues were broadly in line with expectations, the revenue mix was "somewhat skewed to areas with a lower multiple," the analyst stated. The company's high-quality investment banking arm delivered a revenue miss of 9%, he added.
Despite the softer earnings, Jefferies Financial Group is "one of the best places to play the capital markets recovery, given ongoing share gains in recent years, and relatively attractive valuation," Yaro further wrote.
JEF Price Action: Shares of Jefferies Financial Group finished 0.69% higher at $80.13 on Wednesday.
Read Next:
<ul>
<li> <a href="https://www.benzinga.com/news/earnings/25/01/42887725/jefferies-financial-group-reports-better-than-expected-q4-results-eps-beat-net-revenues-up-73-year-over-year">Jefferies Financial Group Reports Better-Than-Expected Q4 Results: EPS Beat, Net Revenues Up 73% Year-Over-Year</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Earnings Beats

Long Ideas

Price Target

Reiteration

Analyst Ratings

Jefferies Q4 Margins Disappoint, Analyst Sees It As Top Market Rebound Bet

Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) has dropped 3.5% in seven days, yet traders remain optimistic suggesting a <a href="https://www.benzinga.com/money/shiba-inu-price-prediction">potential bullish rally</a>.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td> $0.00002186</td>
<td>$12.2 billion</td>
<td>+1.4%</td>
<td> -3.5% </td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td> $0.3342</td>
<td>$47.5 billion</td>
<td>+3% </td>
<td>-0.8% </td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td> $0.00001779</td>
<td>$7.1 billion</td>
<td> -1.7%</td>
<td>-13% </td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Rose Premium Signals analyzed the retracement within Shiba Inu's ascending channel, identifying $0.00001623 as a key long-entry zone. 
He noted the pullback aligns with strong Fibonacci levels, forming a robust foundation for the next upward move.
Post-correction targets include: $0.00002800 (first target), $0.00003500 (second target) and $0.00004170 (final target). The trader <a href="https://x.com/VipRoseTr/status/1877089109975486850">believes</a> this retracement reflects healthy accumulation, reinforcing SHIB's ongoing bullish trend.
Statistics: IntoTheBlock data shows Shiba Inu large transaction volume dropped 93.1% to $51.7 million while daily active addresses remained flat. 
Transactions greater than $100,000 decreased from 181 to 165 transactions.
Shibariumscan data shows daily transactions have been consistently staying above the 4.7 million mark since more than a month. 
As of Jan. 8, it stands at 4.77 million compared to 4.76 million as of Jan. 7.
CryptoDep <a href="https://x.com/Crypto_Dep/status/1877290612996677809">data</a> shows Shiba Inu ranks among the top 10 meme tokens by social activity, occupying the seventh spot with: 11,100 posts, 1.55 million interactions and 1.15% social dominance.
Community News: In a recent <a href="https://www.youtube.com/watch?v=xR8g46P_9Rc">podcast</a>, Shytoshi Kusama highlighted the distinct roles of SHIB, BONE, LEASH, and the upcoming TREAT token, scheduled to launch on Jan. 14. 
He emphasized that the TREAT token will focus on innovation and marketing, complementing the ecosystem&#8217;s decentralized decision-making framework.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42855602/dogecoin-down-6-shiba-inu-slumps-8-what-is-going-on">Dogecoin Down 6%, Shiba Inu Slumps 8%: What Is Going On?</a></li>
</ul>
Image: Shutterstock

$DOGE

$PEPE

$SHIB

'Dogecoin Killer' Shiba Inu Down 3.5% In 7 Days: Is This Really 'Healthy Accumulation'?

Mark Cuban, the billionaire entrepreneur and longtime investor on Shark Tank, has always been a fan favorite. Known for his outspoken personality and sharp business acumen, Cuban recently shared his thoughts on his fellow Sharks, saying, &#8220;All of them have their own thing,&#8221; and spilled some tea on what it's really like working with them.
When asked how he'd rank the Sharks during an <a href="https://www.youtube.com/watch?v=fiK6IWhDbWU">appearance</a> on Theo Von's Podcast, Cuban jokingly said, "You put me in the bad spot! They're all tied for last." But he didn't hold back when breaking down each Shark's unique personality and approach.
Don't Miss:
<ul>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
<h2 class="wp-block-heading">The Sharks, According to Cuban</h2>
<ul>
<li>Barbara Corcoran: Cuban called her his favorite, praising her ability to read people. "She'll just say to somebody, ‘You're lying' or ‘You're dishonest,' and she'll be right," he said. However, Cuban added with a laugh, "She can't do math. Like, I'll have to tell her what eight times eight is."</li>
<li>Kevin O'Leary: Known as the show's "bad guy," <a href="https://www.benzinga.com/news/24/12/42559810/people-think-kevin-oleary-is-the-mean-shark-but-he-says-im-not-mean-i-just-tell-the-truth-to-keep-families-from-going-broke">Kevin embraces his villainous persona</a>. Cuban didn't elaborate much, simply saying, "Kevin's Kevin."</li>
<li>Robert Herjavec: Cuban described Robert as being into "pets and kids and stuff like that," highlighting his softer side.</li>
<li>Lori Greiner: As the "queen" of consumer products, Lori is a natural for retail-focused businesses.</li>
<li>Daymond John: Dubbed the "people's Shark," Daymond focuses on helping smaller businesses grow.</li>
</ul>
As for himself, Cuban admitted he's mostly there to have fun and occasionally stir things up among the group – &#8220;I just f&#x2A;&#x2A;&#x2A; with all of them!&#8221;
See Also: With 100+ historic trademarks including some of the high grossing characters in history, like Cinderella, Snow White and Peter Pan, <a href="https://www.benzinga.com/money/elf-labs-1">this company is transforming the $2 trillion entertainment market with patented AR, VR, and AI tech. — For a short window, investors are able to claim $2/share ($980 min).</a>
<h2 class="wp-block-heading">The Price of Wealth and Fame</h2>
Cuban also opened up about the lesser-known downsides of being a billionaire. One major issue? Lawsuits. "People sue you. You're the deep pockets," Cuban explained. "I've been sued five times and four of them were just people trying to get money." As someone with "deep pockets," Cuban said he's often targeted unfairly.
His family is also impacted by his public persona. The particular difficulties faced by Cuban&#8217;s children include increased scrutiny. If they mess up, &#8220;it's on the front page of the paper because you're my kid," he said. Cuban shared how one of his sons recently asked for a "normal" moment, saying, "When you're there, <a href="https://www.benzinga.com/startups/24/12/42594446/shark-tanks-mark-cuban-backs-portable-golf-game-despite-his-hate-for-golf-ill-do-videos-of-this-even-at-a-pga-event-2">everything changes</a>." While heartbreaking, Cuban said he understands.
<h2 class="wp-block-heading">Shark Tank Profits and Purpose</h2>
Despite investing nearly $20 million in startups on Shark Tank, Cuban <a href="https://www.benzinga.com/startups/24/12/42618228/mark-cuban-admits-ive-gotten-beat-after-losing-20-million-on-shark-tank-startups">admitted he hasn't turned a profit</a>. Speaking on the Full Send Podcast in 2022, he said, "Oh no, I've gotten beat." His biggest flop? Breathometer, a smartphone Breathalyzer that earned backing from all five Sharks. While it had potential, poor management and an FTC settlement over faulty readings ultimately tanked the company.
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/connect-invest-real-estate-notes">These high-yield real estate notes that pay 7.5% &#8211; 9% make earning passive income easier than ever.</a>
Still, as he reflected on his time on the show, <a href="https://www.benzinga.com/personal-finance/24/12/42380333/mark-cubans-favorite-shark-tank-product-was-created-just-for-dudes-and-is-raking-in-over-100-million-a-year-wipe-early-wipe-often">Cuban highlighted Dude Wipes</a> as one of his favorite investments. The personal hygiene brand has grown into a $100 million business, which he said is "killing it." On the flip side, Cuban regrets not investing in Spikeball, a backyard sports game that became wildly popular. "Every time I see it, it just reminds me I missed out," he admitted.
But for Cuban, Shark Tank is about more than money. "It teaches kids about the power of entrepreneurship," he said. He's proud that the show inspires people to chase the American dream and take risks.
<h2 class="wp-block-heading">Shark No More</h2>
After 14 seasons, Cuban stepped away to spend more time with his family, especially his teenage kids. "I've missed [time with them] for so long. Now they're teenagers, I just don't want to miss any more of that time," he told Good Morning America.
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.26/share!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

She Can't Do Math And He's The Bad Guy – Billionaire Mark Cuban Ranks All The Sharks On Shark Tank

Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) has outperformed the market over the past 20 years by 17.56% on an annualized basis producing an average annual return of 25.87%. Currently, Amazon.com has a market capitalization of $2.33 trillion. 
Buying $1000 In AMZN: If an investor had bought $1000 of AMZN stock 20 years ago, it would be worth $99,654.55 today based on a price of $221.40 for AMZN at the time of writing.
<h3>Amazon.com's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736439308_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today

In the current market session, MACOM Technology Solns Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSI#NASDAQ">MTSI</a>) share price is at $136.03, after a 0.43% increase. Moreover, over the past month, the stock decreased by 0.69%, but in the past year, spiked by 60.89%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1736439307_0.png" alt="Past Year Chart" />

<h3>A Look at MACOM Technology Solns P/E Relative to Its Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of 54.38 in the Semiconductors &amp; Semiconductor Equipment industry, MACOM Technology Solns Inc. has a higher P/E ratio of 130.34. Shareholders might be inclined to think that MACOM Technology Solns Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1736439307_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

MTSI

P/E Ratio Insights for MACOM Technology Solns

Wells Fargo analyst Joseph O'Dea maintains Acuity Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYI#NYSE">AYI</a>) with a Equal-Weight and raises the price target from $320 to $336.

Wells Fargo Maintains Equal-Weight on Acuity Brands, Raises Price Target to $336

Royal Bank Of Canada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RY#NYSE">RY</a>) disclosed its partnership with Cohere to co-develop a generative AI solution<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n42893498/rbc-and-cohere-partner-to-develop-the-next-generation-of-highly-secure-generative-ai-solutions-for" rel="noreferrer noopener"> tailored for financial services</a>.
Cohere is a security and privacy-focused enterprise AI. The companies aim to create a secure generative AI platform called North for Banking.
North for Banking will integrate with both RBC&#8217;s and Cohere&#8217;s proprietary models, as well as RBC&#8217;s internal platforms.
The solution will use both companies&#8217; AI models and RBC&#8217;s internal systems to speed up AI development, focusing on improving security and risk management for the financial sector.
Cohere co-founder Ivan Zhang stated that North for Banking is a complete AI solution designed to help financial firms boost productivity and efficiency. With a strong focus on security and data privacy, companies can confidently adopt the platform on a large scale.
Royal Bank of&nbsp;Canada plans to host an Investor Day on&nbsp;Thursday, March 27, 2025, with presentations given by&nbsp;CEO Dave McKay and other management team members.
Investors can gain exposure to the stock via ETF Opportunities Trust Brendan Wood TopGun Index ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/BWTG#BATS">BWTG</a>).
Price Action: RY shares closed higher by 0.28% at $121.67 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42823979/canadas-pm-justin-trudeau-steps-down-amid-internal-conflict-and-tension-over-trump-tariffs" target="_blank" rel="noreferrer noopener">Justin Trudeau Will Step Down As Canada Faces Tension Over Trump Tariffs</a></li>
</ul>
Photo via Shutterstock.

Equities

Large Cap

BWTG

RBC Teams Up with Cohere For GenAI Financial Solutions: Details

AutoZone's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) short percent of float has risen 21.86% since its last report. The company recently reported that it has 333 thousand shares sold short, which is 2.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.17 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AutoZone Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736438422_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AutoZone has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing AutoZone's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AutoZone's peer group average for short interest as a percentage of float is 9.83%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About AutoZone?

Burlington Stores's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) short percent of float has risen 23.61% since its last report. The company recently reported that it has 2.30 million shares sold short, which is 4.66% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.77 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Burlington Stores Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736438416_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Burlington Stores has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Burlington Stores's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Burlington Stores's peer group average for short interest as a percentage of float is 12.74%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

BURL

How Is The Market Feeling About Burlington Stores?

Biogen's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NYSE">BIIB</a>) short percent of float has fallen 5.21% since its last report. The company recently reported that it has 2.58 million shares sold short, which is 2.0% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.94 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Biogen Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736438411_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Biogen has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Biogen's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Biogen's peer group average for short interest as a percentage of float is 5.09%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

BIIB

Peering Into Biogen's Recent Short Interest

Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) has outperformed the market over the past 20 years by 1.43% on an annualized basis producing an average annual return of 9.73%. Currently, Charles Schwab has a market capitalization of $133.81 billion. 
Buying $1000 In SCHW: If an investor had bought $1000 of SCHW stock 20 years ago, it would be worth $6,409.13 today based on a price of $73.10 for SCHW at the time of writing.
<h3>Charles Schwab's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736438409_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

SCHW

Here's How Much You Would Have Made Owning Charles Schwab Stock In The Last 20 Years

Cantor Fitzgerald analyst Jonathan Ruykhaver initiates coverage on SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) with a Overweight rating and announces Price Target of $30.

Initiation

Cantor Fitzgerald Initiates Coverage On SentinelOne with Overweight Rating, Announces Price Target of $30

On Thursday, Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) released results from the IRAKLIA phase 3 study evaluating the non-inferiority of Sarclisa (isatuximab) subcutaneous formulation via an on-body delivery system (OBDS) versus weight-based dosed Sarclisa IV in combination with pomalidomide and dexamethasone (Pd) in adult patients with relapsed or <a target="_blank" href="https://www.benzinga.com/general/biotech/24/06/39169252/sanofi-highlights-data-from-blood-cancer-drug-sarclisa-in-new-diagnosed-multiple-myeloma-patients" rel="noreferrer noopener">refractory multiple myeloma</a>.&nbsp;
The <a target="_blank" href="https://www.sanofi.com/en/media-room/press-releases/2025/2025-01-09-06-00-00-3006798" rel="noreferrer noopener">trial</a> demonstrated that Sarclisa SC, in combination with pomalidomide and dexamethasone (Pd), met its co-primary endpoints of non-inferior objective response rate and observed concentration before dosing (C trough) at steady state.
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42530062/sanofis-340b-credit-proposal-draws-federal-warning-for-statutory-violation" rel="noreferrer noopener">Sanofi&#8217;s 340B Credit Proposal Draws Federal Warning For Statutory Violation</a>
Key secondary endpoints were also achieved, including very good partial response, the incidence rate of infusion reactions, and C trough at cycle 2.
The study is ongoing, and the full results will be presented at a forthcoming medical meeting.
Additional studies evaluating Sarclisa SC formulations across different combinations and lines of therapy are ongoing.
The safety and efficacy of Sarclisa SC and the enFuse device have not been evaluated by any regulatory authority outside of their approved indications. Regulatory submissions in the US and in the EU are planned during the first half of 2025.
In September, the FDA approved&nbsp;Sarclisa (isatuximab) in combination with bortezomib, lenalidomide, and dexamethasone (VRd) as a first-line treatment option for adult patients with newly diagnosed multiple myeloma who are not eligible for autologous <a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/40979253/sanofis-sarclisa-secures-fda-approval-for-first-line-multiple-myeloma-marking-its-third-us-approv" rel="noreferrer noopener">stem cell transplant</a>.
In August, Sanofi released new results from the GMMG-HD7 phase 3 study of Sarclisa in combination with lenalidomide, bortezomib, and dexamethasone (RVd) versus RVd induction followed by post-transplant re-randomization to Sarclisa plus lenalidomide versus lenalidomide maintenance in transplant-eligible newly diagnosed <a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40260365/sanofis-approved-blood-cancer-drug-sarclisa-shows-improved-progression-free-survival-in-patients-" rel="noreferrer noopener">multiple myeloma patients</a>.
The data&nbsp;show&nbsp;that Sarclisa, combined with RVd during induction therapy, significantly prolonged progression-free survival, resulting in a statistically significant and clinically meaningful reduction in disease progression or death compared to RVd induction regardless of the maintenance regimen.
Price Action: SNY stock closed at $49.23 on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42896803/medicare-to-cover-eli-lillys-weight-loss-drug-zepbound-for-obstructive-sleep-apnea-treatment" target="_blank" rel="noreferrer noopener">Medicare To Cover Eli Lilly&#8217;s Weight Loss Drug Zepbound For Obstructive Sleep Apnea Treatment</a></li>
</ul>
Image by HJBC via Shutterstock

Sanofi's Blood Cancer Drug's New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma

Cantor Fitzgerald analyst Jonathan Ruykhaver initiates coverage on Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) with a Neutral rating and announces Price Target of $200.

CHKP

Cantor Fitzgerald Initiates Coverage On Check Point Software with Neutral Rating, Announces Price Target of $200

Cantor Fitzgerald analyst Jonathan Ruykhaver initiates coverage on Varonis Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNS#NASDAQ">VRNS</a>) with a Overweight rating and announces Price Target of $60.

VRNS

Cantor Fitzgerald Initiates Coverage On Varonis Systems with Overweight Rating, Announces Price Target of $60

JMP Securities analyst Patrick Walravens downgrades Paycor HCM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) from Market Outperform to Market Perform.

Downgrades

PYCR

JMP Securities Downgrades Paycor HCM to Market Perform

Keybanc analyst Noah Zatzkin maintains YETI Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) with a Underweight and lowers the price target from $36 to $35.

Comments

Viveon Health Acquisition

Viveon Health Acquisition (VHAQ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga